What exactly is hepatotoxicity, and why should I be worried?

The liver is a vital organ that is responsible for many body functions, including blood cell composition, breakdown of nutrients we eat, balancing cholesterols, and ridding our body of foreign chemicals, such as alcohol and drugs.
liver
Hepatotoxicity is damage that occurs to the liver by chemical means. Medications that we use every day can ultimately be damaging our liver!
Unfortunately, hepatotoxicity from commonly known drugs is often a cause of liver injury. It is estimated as many as 1000 drugs can be blamed for some form of liver damage.
The liver’s role in detoxification makes it especially vulnerable to damaging substances. Liver cells, hepatocytes, can be injured by various pathways depending on the type of drug being metabolized. Reactive particles can destruct the cellular components of the hepatocytes, leading to cell death. Other metabolites alter liver enzymes responsible for drug metabolism leading to toxicity. Drug fragments can also bind to liver proteins initiating an autoimmune attack on the liver tissue.
Effects of hepatotoxicity can be seen throughout the body. General symptoms include: nausea, vomiting, upper right stomach pain, loss of appetite, brown urine, and yellowing of the skin and eyes (jaundice.) It is important to note these changes early and notify the health-care provider immediately if they are experienced. Early intervention is the safest way to limit damage to the liver!
Who is at risk for hepatotoxicity? EVERYONE! It may be a patient you are monitoring, a family member you are educating, or yourself. Concerns extend far beyond high dosages of prescription medications. Hepatotoxicity can result from combining multiple drugs, alcohol consumption with medications, genetic predispositions, age-related metabolism rates, and underlying diseases. Over-the-counter products, such as Tylenol, and herbal remedies, that are often considered “safe”, play a HUGE role in liver damage.
The key to lowering your risk is EDUCATION. Knowledge about hepatotoxicity is critical to keeping EVERYONE safe.


Reference:
Kaplowitz, N. (2004). Drug-induced liver injury. Clinical Infectious Diseases: An Official Publication Of The Infectious Diseases Society Of America, 38 Suppl 2S44-8.
http://libproxy.uta.edu:2066/.

More information on hepatotoxicity, like specific symptoms to look out for can be found here: http://www.liverdisordersfocus.com/articles/liver-disorders/drug-induced-liver-damage.php
Showing posts with label Organizations. Show all posts
Showing posts with label Organizations. Show all posts

Tuesday, October 27, 2009

The Take Home Message

Knowledge about key elements in hepatotoxicity is critical to keeping each other safe in an evolving world of healthcare and medicine. Remember:

A valuable resource for information on hepatotoxicity is the FDA!
Investigations into drugs, definative information, and procedures for reporting possible problems associated with a product can be found at http://www.fda.gov/.
Don't forget to ask your health-care provider and pharmacist any questions or concerns!

Over the counter products can cause severe hepatotoxicity!  OTC products are not always "safe." Alcohol, liver infections, and drug/food interactions can be dangerous when used with certain OTC products. Accidental overdoses are common!

Acetaminophen is now the number one cause of acute liver failure in the America!
-Many products other than Tylenol contain acetaminophen (OTC and prescribed)
-Read labels. Remember, APAP is the abbreviation for acetaminophen.
-Calculate your dosages. Do not exceed 4000 mg per day (4 grams) normally.

Diet pills have a long history of complications! Consult your health-care provider with their use.
-Take as directed and dedicate yourself to the lifestyle changes that accompany diet therapies.
-Note any changes indicating hepatotoxicity and contact your heath-care provider immediately!

Alcohol changes your normal liver function!  Alcohol is a damaging chemical to the liver and can cause greater complications with OTC and prescribed therapies.

Food and drug interactions in the liver are serious!
-Grapefruit interactions can be deadly! Grapefruit leads to hepatotoxicity of many medications. Be aware of drug interactions with grapefruit. You may have to alter your diet!
-Fatty foods may impact the liver's ability to process toxins and fuction normally! A liver riddled with fat may not function efficiently.

Herbal products are not regulated by the FDA and are often linked to liver damage!
Tell your health-care provider when you are using herbal therapy in combination with medications. Be aware of interactions your medications may have with certain supplements, including acetaminophen.

Many prescriptions are well known to induce liver damage, including: Cholesterol lowering medications, Antibiotics, and Antidiabetics.
-Ask your health-care provider about side effects of your medications, specifically in the liver.
-Remember many factors can cause hepatotoxicity of prescription drugs including: age, food interactions, alcohol consumption, and other drug interactions.

Hepatotoxicity will likely continue to be an issue as more medications are developed to battle common health issues. The key to avoiding complications with your liver is to stay in the know about current products as well as your own body changes. Too often, the hepatotoxic dangers lurking in the medicine cabinet are unknown to people. Unfortunately, the realization of these dangers can be a situation of "too little, too late" and serious consequences result.

With this in mind, it raises the question, how can we change this outlook in our community? Is it up to the FDA, the healthcare system, or maybe...YOU?? Who will you tell??

For more information on drug-induced hepatotoxicity, please visit:
http://emedicine.medscape.com/article/169814-overview
 http://www.pharmacologyonline.org/PDF/dili.pdf

Sunday, October 18, 2009

FDA and Acetaminophen…… Is it ENOUGH???

It is important to note the that initiation of a strategy to eliminate hepatotoxicity can decrease the number of unintentional overdose cases. There is no one factor that is linked to hepatotoxicity with acetominophen; many conditions often contribute to this problem.
Below is a list of ways that the FDA has recommended to reduce the occurrences of acetominophen hepatotxicity:

1. Enhance public education efforts (also may reduce intentional overdoses)
  • Develop concise, clear messages
  • Increase partnerships with other governmental agencies, health professionals, industry, consumers, and media
2. Improve labeling
  • Prominently display the name acetaminophen on principal display panel
  • Include warning that taking more than recommended amount may cause severe liver injury and should not be used with other products containing acetaminophen (on the container and box)
  • Include warning about need for prompt medical attention after acetaminophen overdose even when no symptoms of a health problem are present
  •  Include warnings for people with liver disease and alcohol users
3. Limit the maximum adult daily dose to an amount no greater than 3250 mg, except there should be a lower daily maximum for patients taking 3 or more alcoholic drinks every day while using acetaminophen products.

 4. Limit the tablet strength for immediate-release forms to 325 mg, single adult dose to 650 mg, and extended-release forms commensurate with total daily dose.

5. Limit options in pediatric liquid formulations
  •  Limit pediatric liquid formulation to one mid-strength concentration
  •  Require that a measuring device be included in each package
  •  Include dosing instructions for children under 2 years if accurate dosing instructions can be determined.
6. Eliminate combination products

References:
John R. Senior, M. L. (2009, July 31). Drug-Induced Liver Toxicity. Retrieved October 11, 2009, from Food Drug Administration: http://www.fda.gov/Drugs/scienceresearch/researchareas/ucm071471.htm


The Acetaminophen Hepatotoxicity Working Group Center for Drug and Evaluation Research, F. D. (2008). Recommendations for FDA Interventions to Decrease the Occurance of Acetaminophen Hepatotoxicity.

Monday, October 12, 2009

Who is Helping to Prevent Hepatotoxicity?

Approximately 1000 drugs have been linked to liver injury. Liver damage is the most common reason drugs are taken of the market. Drug induced liver injury is responsible for 5% of all hospital admissions and 50% of all acute liver failures (i.e. sudden liver failure.) In fact, the leading cause of acute liver failure (ALF) results from hepatotoxicity!




Government agencies play a pivotal role in the prevention and regulation of drugs linked with liver injury. FDA intervention strategies can significantly decrease the number of cases of drug overdose leading to liver injury from over-the-counter and prescription drug products. Organizations such as the Center for Drug Evaluation and Research (CDER), Office of Surveillance and Epidemiology (OSE), American Association for the Study of Liver Diseases (AASLD), Drug-Induced Liver Injury Network (DILIN), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and Pharmaceutical Research and Manufactures of America all recognize the severity of hepatoxicity.

Can we do more to reduce drug-induced hepatotoxicity? How can we make people taking these medications active in this process?


References:
John R. Senior, M. L. (2009, July 31). Drug-Induced Liver Toxicity. Retrieved October 11, 2009, from Food Drug Administration: http://www.fda.gov/Drugs/scienceresearch/researchareas/ucm071471.htm

Melissa Palmer, M. (n.d.). MEDICATIONS AND THE LIVER/HEPATITIS. Retrieved October 17, 2009, from http://www.liverdisease.com/medications_hepatitis.html

Hepatotoxicity: Where We've Been, Where We Are, Where We're Going

HISTORY

Hepatotoxicity dates back to nearly 100 years. Just recently, they have discovered that some of the most common drugs can cause liver injury. These drugs are currently well known to the public and used by a majority of the population. The drugs in question are known as non-steroid anti-inflammatory drugs (NSAIDS), statins, anti-diabetics, and acetaminophen.

- Acetaminophen was known to cause liver damage in 1943, if not taken in therapeutic range. Even when taken appropriately, can cause hepatotoxicity if taken with other medications.
- The anti-diabetic drug, troglitazone, was the first drug to bring light to hepatotoxicity and the long-term causes it can have on the liver.

TODAY

Hundreds of articles exist on the effects of drugs on the liver. The drug industry has been hit hard with removal of drugs from the market that cause liver damage. Liver hepatotoxicity is one of the most common reasons that drugs are withdrawn from the public's use. Even doses in the therapeutic range, have been known to cause toxicity of the liver. Although these drugs were known to work effectively, they were shown to cause severe liver damage, liver transplant, or death.

In 2006, the FDA added guidelines to follow if the immune system falls below a certain range. Liver enzymes should be tested in order to keep patients safe. This is currently the only way to diagnosis liver hepatoxicity, at least the most efficient way.

Recently, the public has become aware of acetaminophen related hepatotoxicity. One controversy on OTC drugs is the drug-drug interactions. The public is not as educated as they should be on the ease of overdosing on OTC drugs. As healthcare professionals, it should be an important goal to educate patients on liver safety.


WHAT THE FUTURE HOLDS

Drug companies will have a never-ending battle with regulating the side effects of drugs. It could be considered a catch 22, drugs can dramatically improve ones life and at the same time be a silent killer. The FDA has taken steps to educate the public on these drugs, but the warnings do not seem to be eye catching enough.

Studies show that there is a possible genetic link to drug induced liver injury. Science Daily (2009) studies show that acetaminophen is toxic if taken in high doses, but a link exists showing that toxicity is more likely due to genetics. The study suggests that finding the genetic marker will help create safer drugs in the future. Studies also suggest that some patients become more susceptible due to their environmental factors.

Current preclinical and clinical liver safety testing does an excellent job in keeping the public safe from drugs capable of causing various forms of liver injury.

In any case, the FDA will constantly be on alert for drugs and their contraindications for hepatotoxicity. Healthcare professionals will need to be aware of the ever-changing revisions to drugs and safety changes.


References:

Lucena, M., García-Cortés, M., Cueto, R., Lopez-Duran, J., & Andrade, R. (2008). Assessment of drug-induced liver injury in clinical practice. Fundamental & Clinical Pharmacology, 22(2), 141-158. http://search.ebscohost.com/

Watkins, P. (2005). Idiosyncratic liver injury: challenges and approaches. Toxicologic Pathology, 33(1), 1-5. http://search.ebscohost.com/

Fontana R, Watkins P, Bonkovsky H, et al. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Safety: An International Journal Of Medical Toxicology And Drug Experience [serial online]. 2009;32(1):55-68. Available from: MEDLINE

Ipswich, MA. Accessed October 16, 2009.Lee W, Senior J. Recognizing drug-induced liver injury: current problems, possible solutions. Toxicologic Pathology [serial online]. 2005;33(1):155-164. Available from: MEDLINE, Ipswich, MA. Accessed October 16, 2009.009.